D&D Pharmatech Inc.
Clinical-stage biopharma developing GLP-1 therapies for metabolic and neurodegenerative diseases.
347850 | KO
Overview
Corporate Details
- ISIN(s):
- KR7347850000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 금토로80번길 27 (금토동, 텔레칩스) 4층, 성남시
- Website:
- http://www.ddpharmatech.com/
- Sector:
- Manufacturing
Description
D&D Pharmatech is a clinical-stage biopharmaceutical company specializing in the development of therapies based on GLP-1 (Glucagon-like peptide-1) and related peptides. The company's pipeline primarily targets metabolic diseases, including obesity and MASH (Metabolic dysfunction-associated steatohepatitis), as well as neurodegenerative disorders. A core competency is its proprietary oral peptide delivery technology. Key candidates in its portfolio include DD01, an injectable dual GLP-1/glucagon receptor agonist for MASH that has received FDA Fast Track Designation, and an oral GLP-1 therapy for obesity. The company operates a global model, funding drug development through specialized subsidiaries, with research functions in Korea and clinical development managed by its US-based team.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-10 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 74.1 KB | ||
| 2024-05-09 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청) (대사이상지방간염 (MASH) 치료제 DD01의 제2상 미국 FDA 임상시…
|
Korean | 9.0 KB | ||
| 2024-05-08 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 107.6 KB | ||
| 2024-05-07 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 58.0 KB | ||
| 2024-05-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.8 KB | ||
| 2024-05-07 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 163.8 KB | ||
| 2024-05-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.0 KB | ||
| 2024-05-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.0 KB | ||
| 2024-05-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 20.9 KB | ||
| 2024-05-07 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 20.9 KB | ||
| 2024-05-03 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 64.7 KB | ||
| 2024-04-25 00:00 |
증권발행실적보고서
|
Korean | 113.2 KB | ||
| 2024-04-19 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 757.4 KB | ||
| 2024-04-19 00:00 |
[기재정정]투자설명서
|
Korean | 4.7 MB | ||
| 2024-04-17 00:00 |
투자설명서
|
Korean | 3.9 MB |
Automate Your Workflow. Get a real-time feed of all D&D Pharmatech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for D&D Pharmatech Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for D&D Pharmatech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
